1
|
Baudry E, Huguet S, Couderc AL, Chaibi P, Bret F, Verny C, Weill S, Madar O, Urien S, Rezai K. Cyclophosphamide dose adjustment based on body weight and albuminemia in elderly patients treated with R-mini-CHOP. Cancer Chemother Pharmacol 2019; 83:775-785. [DOI: 10.1007/s00280-019-03775-9] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2018] [Accepted: 01/10/2019] [Indexed: 10/27/2022]
|
2
|
Cornélis F, Cornette P, Moor R, Alibhai S, Korc-Grodzicki B, McCorkle R, Goodwin J, Albrand G, Chaibi P, Caillet P, Monfardini S, Holmes H, Aapro M, Begue A, Tremblay D, Klepin H, Soubeyran P. Geriatric interventions in older cancer patients: International society of geriatric oncology (siog) recommendations. J Geriatr Oncol 2014. [DOI: 10.1016/j.jgo.2014.09.104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
3
|
Spano J, Chaibi P, Vignot S, Thery J, De La Motte Rouge T, Gil-Delgado M, Khayat D, Mouawad R. 4027 POSTER Age-related Changes in Plasma Levels of Inflamatory and Angiogenic Cytokines in Patients With Cancer. Eur J Cancer 2011. [DOI: 10.1016/s0959-8049(11)71270-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
4
|
Chaibi P, Magne N, Breton S, Chebib A, Duron J, Tagzirt M, Hannoun L, Piette F, Khayat D, Spano J. Influence of geriatric consultation with Comprehensive Geriatric Assessment (CGA) on therapeutic decision in elderly cancer patients. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.9505] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
9505 Background: Elderly patients represent an heterogeneous population in which anticancer therapeutic decision is often difficult and may be helped by CGA. We report 2 years activity of the geriatric assessment consultation of our institution, and its impact on therapeutic decision Methods: Since January 2007, we propose a geriatric consultation for elderly cancer patients for whom therapeutic decision appears complex to oncologists. This consultation included a CGA, with focuses on items like comorbidity, dependance, cognitive impairment, depression and malnutrition using international well known scales. Results: 161 patients (57 men, 104 women) (median age 82,4 years, extremes 73 -97) were seen at the geriatric consultation. Most of the patients (134/161) were in fist line treatment for colorectal (54), other digestive (28), breast (30) and pulmonary (14) cancers. Cancer was metastatic in 86 patients (53 %). Geriatric assessment found: severe comorbidity (grade 3 or 4 in CIRS-G scale) in 75 patients, dependance for at least one activity of daily living (ADL) in 52 patients, cognitive impairment in 42 patients, including 13 patients with already diagnosed Alzheimer disease, malnutrition in 104 patients (65 %), depression in 39 patients. According to prior oncologist decision, there have been no change in therapeutic decision in 29 patients only. Geriatric interventional treatment was delivered to 122 patients (76 %). Anticancer treatment was changed in 79 patients (49 %), including delayed therapy in 5 patients, less intensive therapy in 29 patients and more intensive therapy in 45 patients. Patients for whom final decision was delayed or less intensive therapy had significantly more frequent severe comorbidity (23/34, p < 0.01) and dependance for at least one ADL (19/34, p < 0.01). Patients for whom final decision was more intensive therapy had significantly more frequent metastatic disease (33/45, p < 0.01) Conclusions: Geriatric evaluation did influence therapeutic decision in 82 % of the patients. Follow up data will be presented to evaluate quality of final therapeutic decision, especially data concerning dose intensity and toxicity for patients with a more intensive therapy final decision. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- P. Chaibi
- Hopital Charles Foix, Ivry sur Seine, France; Hôpital Pitié Salpétrière, Paris, France
| | - N. Magne
- Hopital Charles Foix, Ivry sur Seine, France; Hôpital Pitié Salpétrière, Paris, France
| | - S. Breton
- Hopital Charles Foix, Ivry sur Seine, France; Hôpital Pitié Salpétrière, Paris, France
| | - A. Chebib
- Hopital Charles Foix, Ivry sur Seine, France; Hôpital Pitié Salpétrière, Paris, France
| | - J. Duron
- Hopital Charles Foix, Ivry sur Seine, France; Hôpital Pitié Salpétrière, Paris, France
| | - M. Tagzirt
- Hopital Charles Foix, Ivry sur Seine, France; Hôpital Pitié Salpétrière, Paris, France
| | - L. Hannoun
- Hopital Charles Foix, Ivry sur Seine, France; Hôpital Pitié Salpétrière, Paris, France
| | - F. Piette
- Hopital Charles Foix, Ivry sur Seine, France; Hôpital Pitié Salpétrière, Paris, France
| | - D. Khayat
- Hopital Charles Foix, Ivry sur Seine, France; Hôpital Pitié Salpétrière, Paris, France
| | - J. Spano
- Hopital Charles Foix, Ivry sur Seine, France; Hôpital Pitié Salpétrière, Paris, France
| |
Collapse
|
5
|
Adam R, Ducreux M, Rougier P, Chaibi P, Mariette C. [Chemotherapy and surgery: how can resection of colorectal cancer metastases to the liver be optimized?]. J Chir (Paris) 2008; 145 Suppl 1:3S5-3S14. [PMID: 19024846] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
|
6
|
Adam R, Ducreux M, Rougier P, Chaibi P, Mariette C. [Management of colorectal cancer and its metastases to the liver]. J Chir (Paris) 2008; 145 Suppl 1:3S1-3S4. [PMID: 19024845] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
|
7
|
Haber N, Paute J, Gouot A, Sevali Garcia J, Rouquet ML, Sahraoui L, Gamard MN, Jarlier V, Chaibi P, Cambau E. Incidence et caractéristiques cliniques des infections urinaires symptomatiques dans un hôpital gériatrique. Med Mal Infect 2007; 37:664-72. [PMID: 17337143 DOI: 10.1016/j.medmal.2006.12.004] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2006] [Accepted: 12/12/2006] [Indexed: 11/20/2022]
Abstract
UNLABELLED OBJECTIVES AND SETTINGS: The authors had for aim to study the incidence of symptomatic urinary infections (SUTI) in elderly patients, to describe their clinical and microbiologic characteristics and first-line treatment in a geriatric hospital with 902 beds: 124 in acute care (ACF), 293 in rehabilitation and intermediate-care (RICF), and 485 in long-term-care-facilities (LTCF). METHOD During two months in 2003, all positive urine cultures detected by the laboratory were sent to the clinician with a questionnaire on clinical signs, diagnosis of SUTI and antibiotic treatment. RESULTS SUTI was diagnosed in 85 out of 204 positive urine cultures (40%). The incidence of SUTI was 1.86 per 1,000 patient-days (with rates of 2.63, 2.49, 1.41 per 1,000 patients-days for the ACF, RICF, LTCF respectively). For 51 cases (60%) there were only general symptoms, for 24 cases (28.2%) there were only urinary symptoms, and for 10 cases (11.8%) there were both. Escherichia coli and Proteus mirabilis were the main bacterial species involved in 57 and 14% respectively. E. coli strains were 59% resistant to amoxicillin, 55% resistant to amoxicillin-clavulanic acid, and 39% resistant to fluoroquinolones. The main antibiotics were fluoroquinolones, ceftriaxone, and amoxicillin-clavulanate, prescribed respectively in 52.5, 19, and 9% of the cases. CONCLUSION SUTI was diagnosed in only in 40% of positive urine cultures from elderly patients hospitalized in our hospital. To improve the management of SUTI in this population, we changed our recommendations for diagnosis and treatment.
Collapse
Affiliation(s)
- N Haber
- Equipe opérationnelle d'hygiène, groupe hospitalier Charles-Foix-Jean-Rostand, Assistance publique-Hôpitaux de Paris, 94000 Ivry-Sur-Seine, France.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Chaibi P, Gouin I, Berigaud S, Siguret V, Pautas E, Schlageter M, Raffoux E, Piette F. 7 High response rate to Epoetin Beta in elderly patients with myelodysplasia (MDS): results of a prospective study. Crit Rev Oncol Hematol 2006. [DOI: 10.1016/s1040-8428(13)70078-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
9
|
Freyer G, Braud AC, Chaibi P, Spielmann M, Martin JP, Vilela G, Guerin D, Zelek L. Dealing with metastatic breast cancer in elderly women: results from a French study on a large cohort carried out by the 'Observatory on Elderly Patients'. Ann Oncol 2005; 17:211-6. [PMID: 16291586 DOI: 10.1093/annonc/mdj043] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Treatment of elderly patients with metastatic breast cancer (MBC) is not clearly defined and seems to vary according to the subjective appreciation of the physician. PATIENTS AND METHODS After interviewing 107 French specialists qualified in oncology, data concerning 1009 MBC patients were collected: 500 patients were between 65 and 74 years and 509 were >75 years of age. Differences in diagnosis and treatment strategy were analyzed for both age groups to identify the physician's criteria of choice and the eventual use of the geriatric assessment among those criteria. RESULTS At diagnosis, synchronous metastatic disease was more frequent in patients over 75 years old (52% versus 39%; P<0.001). Physicians indicated that treatment was based on age and on a subjective evaluation of the patient's general status. Sixty-eight per cent of younger patients and only 31% of older ones received chemotherapy (P<0.001). In the older group drug doses were lower than those usually recommended in three-quarters of cases. Only 10% of physicians considered that they under-treat patients using the FEC 50 regimen. Over 75 years of age, hormone therapy was offered to most patients, including 8% with hormone-independent tumors. Geriatric covariates were never considered. Geriatricians rarely, if ever, played a role in the therapeutic decision. CONCLUSIONS Inclusion of elderly patients with MBC in prospective trials is warranted to define standards of care and reduce heterogeneity in the decision-making process.
Collapse
Affiliation(s)
- G Freyer
- Centre Hospitalier Lyon Sud, service d'oncologie, Pierre Bénite, France.
| | | | | | | | | | | | | | | |
Collapse
|
10
|
Rodriguez C, Pont JC, Gouin-Thibault I, Andrieu AG, Molina T, Le Tourneau A, Le Garff-Tavernier M, Siguret V, Chaibi P. [Plasma cell leukaemia]. Ann Biol Clin (Paris) 2005; 63:535-9. [PMID: 16230292] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2005] [Accepted: 07/07/2005] [Indexed: 05/04/2023]
Abstract
We report a case of primary plasma cell leukaemia, with an absolute count of plasma cells of 53 Giga/L, diagnosed in a 83-year-old woman. The patient's condition improved, with no circulating plasma cells after 3 weeks of treatment, in response to the combination of thalidomide and dexamethasone administered for 5 days followed by thalidomide alone. The clinical presentation, the morphological, flow cytometric and pathophysiological characteristics of the plasma cell leukaemia and the treatment are summarised in this paper.
Collapse
Affiliation(s)
- C Rodriguez
- Laboratoire d'hématologie, Groupe hospitalier Charles Foix Jean Rostand, Ivry Sur Seine
| | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Gholam D, Giacchetti S, Hauteville D, Bouchahda M, Chaibi P, Jasmin C, Lévi F. Chronomodulated fluorouracil (F), leucovorin (L), oxaliplatin (O) with or without irinotecan (I) (chrono FLO or IFLO) in elderly patients (EP) with metastatic colorectal cancer (MCC): A single institution experience. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.8218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- D. Gholam
- Hosp Paul Brousse, Villejuif, France; Hosp Charlefoix, Ivry sur Seine, France; INSERM E0354 Hosp Paul Brousse, Villejuif, France
| | - S. Giacchetti
- Hosp Paul Brousse, Villejuif, France; Hosp Charlefoix, Ivry sur Seine, France; INSERM E0354 Hosp Paul Brousse, Villejuif, France
| | - D. Hauteville
- Hosp Paul Brousse, Villejuif, France; Hosp Charlefoix, Ivry sur Seine, France; INSERM E0354 Hosp Paul Brousse, Villejuif, France
| | - M. Bouchahda
- Hosp Paul Brousse, Villejuif, France; Hosp Charlefoix, Ivry sur Seine, France; INSERM E0354 Hosp Paul Brousse, Villejuif, France
| | - P. Chaibi
- Hosp Paul Brousse, Villejuif, France; Hosp Charlefoix, Ivry sur Seine, France; INSERM E0354 Hosp Paul Brousse, Villejuif, France
| | - C. Jasmin
- Hosp Paul Brousse, Villejuif, France; Hosp Charlefoix, Ivry sur Seine, France; INSERM E0354 Hosp Paul Brousse, Villejuif, France
| | - F. Lévi
- Hosp Paul Brousse, Villejuif, France; Hosp Charlefoix, Ivry sur Seine, France; INSERM E0354 Hosp Paul Brousse, Villejuif, France
| |
Collapse
|
12
|
|
13
|
Gardin C, Chaibi P, de Revel T, Rousselot P, Turlure P, Micléa JM, Nédellec G, Dombret H. Intensive chemotherapy with idarubicin, cytosine arabinoside, and granulocyte colony-stimulating factor (G-CSF) in patients with secondary and therapy-related acute myelogenous leukemia. Club de Réflexion en Hématologie. Leukemia 1997; 11:16-21. [PMID: 9001413 DOI: 10.1038/sj.leu.2400536] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Using a combination of intensive chemotherapy and G-CSF, we conducted a prospective trial designed to improve the complete remission (CR) rate in patients with AML evolving from a primary documented myelodysplastic syndrome (sAML) and therapy-related AML (tAML). Thirty-four patients (median age 61 years) with sAML (25 patients) or tAML (nine patients) entered the study. Induction course consisted of idarubicin (12 mg/m2 of body-surface area per day for 3 days) and intermediate-dose (ID) cytarabine in the 24 younger patients (1 g/m2 of body-surface area as a 2 h infusion every 12 h for 5 days) or standard-dose (SD) cytarabine in the 10 older patients (100 mg/m2 of body-surface area per day as a continuous infusion for 7 days), followed by G-CSF until neutrophil recovery or treatment failure. Nineteen patients (56%, 13/24 in the ID group and 6/10 in the SD group) achieved a CR (14/25 sAML and 5/9 tAML). Early death occurred in four patients, but four additional patients died in CR from treatment-related toxicity (overall toxic death rate 24%). Initial cytogenetics was available in 33 patients. The CR rate was significantly lower in patients with unfavorable cytogenetics compared to patients with intermediate cytogenetics (37% vs 79%). Median remission duration and overall survival were 3 and 9 months, respectively and not different between ID and SD patients. Although the treatment-related toxicity is high, a high CR rate can be obtained in these poor-risk AML patients with the use of intensive chemotherapy in combination with G-CSF, although the role of the latter is still to be proven. Results remain especially poor in patients with unfavorable cytogenetics. New approaches are needed to maintain remission in these high-risk AML patients.
Collapse
Affiliation(s)
- C Gardin
- Department of Hematology, Hôpital Beaujon, Clichy, France
| | | | | | | | | | | | | | | |
Collapse
|
14
|
Lefrère F, Besson C, Datry A, Chaibi P, Leblond V, Binet JL, Sutton L. Transmission of Plasmodium falciparum by allogeneic bone marrow transplantation. Bone Marrow Transplant 1996; 18:473-4. [PMID: 8864468] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
We describe a case of Plasmodium falciparum infection in a Comorian patient undergoing BMT. The patient's last visit to an endemic area was 1 year prior to BMT. The donor left the Comoro Islands 2 months before marrow harvesting. They had both had previous episodes of malaria and were seropositive for Plasmodium falciparum. At the time of BMT, blood smears were negative in both the donor and recipient. On day 12 post-BMT the patient was asymptomatic but a blood smear revealed 12.5% parasitemia. We consider that donors and recipients at risk pre-BMT should routinely be given specific treatment before marrow harvesting and conditioning, independent of the appearance of blood smears.
Collapse
Affiliation(s)
- F Lefrère
- Departement d'Hématologie, Hôpital Pitié-Salpétrière, Paris, France
| | | | | | | | | | | | | |
Collapse
|
15
|
Koeger AC, Lang T, Alcaix D, Milleron B, Rozenberg S, Chaibi P, Arnaud J, Mayaud C, Camus JP, Bourgeois P. Silica-associated connective tissue disease. A study of 24 cases. Medicine (Baltimore) 1995; 74:221-37. [PMID: 7565064 DOI: 10.1097/00005792-199509000-00001] [Citation(s) in RCA: 76] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Abstract
We prospectively studied all patients hospitalized for connective tissue disease (CTD) in our French rheumatology clinic from January 1979 to December 1989. Our aims were 1) to determine if CTDs associated with occupational exposure to silica (Si) are currently observed in a rheumatology clinic, and, if so, 2) to describe the major features of Si-associated CTD, and 3) to specify which individuals are affected by Si-associated CTD. Patients were divided into 2 groups based on their responses to a questionnaire: those who had been exposed to Si, and those who had no occupational exposure to Si. Among the 764 patients with CTD studied, 24 (3%) were patients with Si-associated CTD and 740 (97%) were patients with non-Si-associated CTD. The sex ratio between the 2 groups was significantly different with a high frequency of men and of immigrants in the Si-associated CTD group. Two thirds of the patients exposed to Si were male miners or sandblasters, but the other third had more unusual exposures to Si, which may involve members of all socio-economics sectors and both sexes, such as sculpture or exposure to abrasive powders. Progressive systemic sclerosis (PSS) was significantly more prevalent in the Si-associated CTD group. This group also consisted of patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), dermatomyositis (DM), and other autoimmune diseases. Si-associated CTD was characterized by the frequency of radiologic lung fibrosis, impaired pulmonary function tests, secondary Sjögren syndrome, and antinuclear antibodies. The number of mineral particles and crystalline Si content were raised in all the bronchoalveolar lavage specimens of Si-exposed patients but in none of those of nonexposed patients. In some cases of Si-associated CTD, the disease was reversible after early cessation of Si exposure. Epidemiologic studies are required to confirm our hypothesis that not only PSS and RA but also SLE and DM are associated with occupational exposure to Si. Pending such results, exposure to Si should be sought in the history of any patient with CTD, especially in a male patient with pulmonary signs, and if present, exposure should be stopped. In the meantime, steps should be taken to ensure that workers exposed to Si in all environments have adequate protection.
Collapse
Affiliation(s)
- A C Koeger
- Department of Rheumatology, Hôpital Pitié-Salpêtrière, Paris, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Tardif S, de Kerviler E, Chaibi P, Guermazi A, Zagdanski AM, Frija J, Degos L, Laval-Jeantet M. CT and MR patterns of spinal involvement in Richter syndrome. J Comput Assist Tomogr 1995; 19:146-9. [PMID: 7822534 DOI: 10.1097/00004728-199501000-00030] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
Richter syndrome is the transformation of chronic lymphocytic leukemia (CLL) into large cell lymphoma. Besides the involvement of lymph nodes, liver, and spleen, bone lesions occur infrequently. We report one case of a patient with a paraspinous mass and destruction of the vertebra by large cell transformation of CLL seen on CT and MRI. There was nothing specific about the clinical presentation, imaging characteristics, and histopathological pattern of bone biopsy that would allow for confident differentiation from infectious spondylitis.
Collapse
MESH Headings
- Diagnosis, Differential
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell/diagnostic imaging
- Leukemia, Lymphocytic, Chronic, B-Cell/pathology
- Lumbar Vertebrae/diagnostic imaging
- Lumbar Vertebrae/pathology
- Lymphoma, Large B-Cell, Diffuse/diagnostic imaging
- Lymphoma, Large B-Cell, Diffuse/pathology
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Spinal Neoplasms/diagnostic imaging
- Spinal Neoplasms/pathology
- Spondylitis/diagnosis
- Syndrome
- Thoracic Vertebrae/diagnostic imaging
- Thoracic Vertebrae/pathology
- Tomography, X-Ray Computed
- Tuberculosis, Spinal/diagnosis
Collapse
Affiliation(s)
- S Tardif
- Department of Radiology, Hospital Saint-Louis, Paris, France
| | | | | | | | | | | | | | | |
Collapse
|
17
|
Koeger AC, Chaibi P, Rozenberg S, Roche B, Oberlin F, Moser G, Laredo JD, Bourgeois P. [Neurologic complications of osteoporotic spinal collapses. Apropos of 8 cases]. Rev Rhum Ed Fr 1993; 60:879-90. [PMID: 8012313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
The prevalence of neurological complications in patients with osteoporotic vertebral collapse and the risk factors for neurological compromise were studied retrospectively in 138 inpatients. Six per cent of patients had objective neurological loss. Patients with neurological loss were more likely to have changes suggestive of malignant disease on roentgenograms, computed tomography, and magnetic resonance imaging. Diagnosis was based on magnetic resonance imaging and examination of vertebral biopsy specimens. Comparison of patients with and without neurological loss suggested that an intravertebral vacuum phenomenon and/or a cortical osteoporosis may cause fracture of the posterior wall and therefore compression of neurological structures.
Collapse
Affiliation(s)
- A C Koeger
- Service de Rhumatologie, Hôpital de la Pitié, Paris
| | | | | | | | | | | | | | | |
Collapse
|
18
|
Karmochkine M, Chaibi P, Rogeaux O, Koeger AC, Bourgeois P. [Chemical meningitis simulating infectious meningitis after intradural injection of corticosteroids]. Presse Med 1993; 22:82. [PMID: 8493211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
|
19
|
Koeger AC, Rozenberg S, Chaibi P, Camus JP, Bourgeois P. [Tiopronin-induced polymyositis confirmed by histology]. Rev Rhum Ed Fr 1993; 60:78-79. [PMID: 8242034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
|
20
|
Bennis R, Cabane J, Giral P, Blétry O, Chaibi P, Wattiaux M, Picard O, Lebas J, Imbert J, Godeau P. Évaluation objective de la sclérodermie par le slip-test : résultats et validation sur 30 malades et 60 témoins. Rev Med Interne 1991. [DOI: 10.1016/s0248-8663(05)82888-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|